Atara Biotherapeutics Inc (ATRA) Insider Trading
- $3,819,989.71
- $54,474,671.30
- Nov. 18, 2024
- Isaac E Ciechanover
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 22, 2021 | Insider | 10,500 | $17.00 | Sell | $178,500.00 | |
Aug. 30, 2021 | Insider | 3,500 | $15.00 | Sell | $52,500.00 | |
Aug. 17, 2021 | EVP | 2,152 | $12.53 | Sell | $26,964.56 | |
Aug. 17, 2021 | SVP | 2,080 | $12.53 | Sell | $26,062.40 | |
Aug. 17, 2021 | CFO | 3,579 | $12.53 | Sell | $44,844.87 | |
Aug. 17, 2021 | CEO | 8,223 | $12.53 | Sell | $103,034.19 | |
Aug. 17, 2021 | Insider | 2,426 | $12.53 | Sell | $30,397.78 | |
June 14, 2021 | Insider | 32,333 | $14.57 | Buy | $471,091.81 | |
June 11, 2021 | Insider | 2,021 | $14.50 | Buy | $29,304.50 | |
June 8, 2021 | CFO | 5,820 | $14.06 | Sell | $81,829.20 | |
May 17, 2021 | Insider | 3,500 | $15.00 | Sell | $52,500.00 | |
March 26, 2021 | Insider | 2,640 | $14.58 | Sell | $38,491.20 | |
March 26, 2021 | CFO | 1,761 | $14.58 | Sell | $25,675.38 | |
March 15, 2021 | COO | 7,000 | $17.41 | Sell | $121,870.00 | |
Feb. 8, 2021 | CFO | 1,759 | $20.39 | Sell | $35,866.01 | |
Feb. 8, 2021 | Insider | 3,886 | $20.39 | Sell | $79,235.54 | |
Jan. 15, 2021 | Insider | 7,000 | $18.84 | Sell | $131,880.00 | |
Dec. 16, 2020 | Insider | 7,000 | $23.11 | Sell | $161,770.00 | |
Nov. 13, 2020 | COO | 7,500 | $18.49 | Sell | $138,675.00 | |
Aug. 18, 2020 | CEO | 4,807 | $12.09 | Sell | $58,116.63 | |
Aug. 18, 2020 | Insider | 1,678 | $12.09 | Sell | $20,287.02 | |
Aug. 18, 2020 | CFO | 1,496 | $12.09 | Sell | $18,086.64 | |
June 25, 2020 | CEO | 12,135 | $12.92 | Sell | $156,784.20 | |
April 6, 2020 | Insider | 657 | $7.94 | Sell | $5,216.58 | |
March 27, 2020 | CFO | 1,827 | $9.17 | Sell | $16,753.59 | |
March 27, 2020 | Insider | 2,740 | $9.17 | Sell | $25,125.80 | |
Feb. 6, 2020 | Insider | 4,117 | $14.21 | Sell | $58,502.57 | |
Feb. 6, 2020 | CFO | 1,781 | $14.21 | Sell | $25,308.01 | |
Sept. 27, 2019 | Insider | 3,500 | $13.51 | Sell | $47,285.00 | |
June 27, 2019 | Director | 2,000 | $19.50 | Buy | $39,000.00 | |
May 30, 2019 | CEO | 5,850 | $23.09 | Sell | $135,076.50 | |
May 14, 2019 | CEO | 7,800 | $24.61 | Sell | $191,958.00 | |
May 6, 2019 | Insider | 1,500 | $35.00 | Sell | $52,500.00 | |
April 26, 2019 | CEO | 7,800 | $33.54 | Sell | $261,612.00 | |
April 10, 2019 | CEO | 3,900 | $37.04 | Sell | $144,456.00 | |
April 1, 2019 | Insider | 1,500 | $39.96 | Sell | $59,940.00 | |
March 29, 2019 | CEO | 7,800 | $38.66 | Sell | $301,548.00 | |
March 15, 2019 | Director | 20,000 | $38.25 | Sell | $765,000.00 | |
March 15, 2019 | CEO | 7,800 | $39.48 | Sell | $307,944.00 | |
March 1, 2019 | Insider | 1,500 | $36.13 | Sell | $54,195.00 | |
Feb. 28, 2019 | Director | 62,590 | $36.07 | Sell | $2,257,621.30 | |
Feb. 28, 2019 | CEO | 7,800 | $36.14 | Sell | $281,892.00 | |
Feb. 15, 2019 | EVP | 775 | $39.59 | Sell | $30,682.25 | |
Feb. 15, 2019 | SVP | 5,909 | $40.00 | Sell | $236,360.00 | |
Feb. 12, 2019 | CEO | 7,800 | $38.77 | Sell | $302,406.00 | |
Feb. 11, 2019 | EVP | 13,975 | $38.55 | Sell | $538,736.25 | |
Feb. 6, 2019 | EVP | 12,375 | $38.62 | Sell | $477,922.50 | |
Feb. 1, 2019 | Insider | 1,000 | $37.80 | Sell | $37,800.00 | |
Jan. 24, 2019 | CEO | 7,800 | $35.06 | Sell | $273,468.00 | |
Jan. 10, 2019 | CEO | 7,800 | $34.55 | Sell | $269,490.00 |
Insiders are both buying and selling Atara Biotherapeutics Inc stock.
The insider traders at Atara Biotherapeutics Inc are: Isaac E Ciechanover, Joe Newell, Christopher Haqq, Carol Giltner Gallagher, John Mcgrath, Pascal Touchon, Utpal Koppikar, Gad Soffer, Amar Murugan, Jakob Dupont, Eric J Hyllengren, Mitchall G Clark, Anhco Nguyen, Derrell Porter, Joel S Marcus, Eric Dobmeier, Kristin Yarema, Matthew K Fust, Mitchall G. Clark, Jill Henrich, Heather D Turner, William K Heiden, Domain Partners Viii, L.P., and Isaac E. Ciechanover
The most active insider trader at Atara Biotherapeutics Inc is Isaac E Ciechanover with 102 trades.
Isaac E Ciechanover has sold the most Atara Biotherapeutics Inc stock with a total value of $26,010,505.70.
Domain Partners Viii, L.P. has bought the most Atara Biotherapeutics Inc stock with a total value of $5,459,498.00.
The most recent insider trade for Atara Biotherapeutics Inc was on Nov. 18, 2024.
The single biggest insider buy for Atara Biotherapeutics Inc was from Domain Partners Viii, L.P. with a total value of $2,729,749.00 on Oct. 21, 2014.
The single biggest insider sell for Atara Biotherapeutics Inc was from Isaac E Ciechanover with a total value of $2,336,000.00 on July 10, 2018.